Gladden Longevity Podcast
Gladden Longevity Podcast
Gladden Longevity Podcast
The Interplay of Growth Hormones and Aging - Episode 363
49 minutes Posted Nov 5, 2026 at 5:00 pm.
Understanding Aging: A Biological Perspective 02:47 The Role of Growth Hormones and mTOR in Aging 06:08 Rapamycin: Potential Benefits and Considerations 09:04 The Dog Aging Project: Insights from Canine Studies 17:02 The Connection Between Humans and Dogs 26:52 Exploring GLP-1 and SGLT-2 Medications 28:12 Exploring GLP-1 Agonists and SGLT2 Inhibitors 30:19 The Role of Hormones in Aging 34:55 AI's Impact on Aging Research 39:41 Regulatory Challenges in Longevity Medicine 42:02 Gene Therapy: Opportunities and Risks 46:40 Central Mechanisms of Aging and Reprogramming To learn more about Dr. Matt Kaeberlein:IG: instagram.com/mkaeberlein LinkedIn: https://www.linkedin.com/in/mkaeberlein/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.
0:00
49:02
Download MP3
Show notes
Dr. Gladden and Dr. Matt Kaeberlein dives into the complexities of aging, discussing its biological underpinnings, the role of growth hormones and mTOR, and the potential of rapamycin in extending healthspan. They also explore the Dog Aging Project, highlighting insights from canine studies, and the profound connection between humans and their pets. The conversation concludes with a discussion on GLP-1 and SGLT-2 medications and their implications for aging and chronic disease management. In this conversation, Dr. Gladden and Matt Kaeberlein delve into the latest advancements in aging research, discussing the potential of GLP-1 agonists and SGLT2 inhibitors, the role of hormones in aging, and the impact of AI on medical research. They explore the regulatory challenges faced by longevity medicine, the opportunities and risks associated with gene therapy, and the central mechanisms of aging and reprogramming. The discussion highlights the complexities of aging biology and the potential for innovative interventions to enhance healthspan and lifespan.   For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!     Takeaways ·       Definitions matter in understanding aging. ·       Aging is an exponential biological process, not linear. ·       mTOR is a volume knob, not an on-off switch. ·       Rapamycin shows promise with minimal side effects. ·       Balance between growth and recycling is crucial. ·       Social environments for dogs lower disease risk. ·       Oxytocin plays a significant role in health. ·       Clinical trials can yield misleading results. ·       SGLT2 inhibitors may slow aging in animal models. ·       Companion animals can help reduce chronic stress. GLP-1 agonists and SGLT2 inhibitors show promise in modulating aging biology. ·       Hormones play a crucial role in aging and longevity. ·       AI technology is rapidly advancing and could revolutionize aging research. ·       Regulatory bodies like the FDA may slow down innovation in longevity medicine. ·       Gene therapy presents both opportunities and risks in the field of aging. ·       Epigenetic reprogramming has the potential for significant positive effects on healthspan. ·       Not all aspects of aging can be reversed through current interventions. ·       The understanding of aging biology is still evolving and requires more research. ·       There are central mechanisms of aging that could be targeted for rejuvenation. ·       The future of aging research is likely to involve a combination of therapies and technologies.   Chapters 00:00 Understanding Aging: A Biological Perspective 02:47 The Role of Growth Hormones and mTOR in Aging 06:08 Rapamycin: Potential Benefits and Considerations 09:04 The Dog Aging Project: Insights from Canine Studies 17:02 The Connection Between Humans and Dogs 26:52 Exploring GLP-1 and SGLT-2 Medications 28:12 Exploring GLP-1 Agonists and SGLT2 Inhibitors 30:19 The Role of Hormones in Aging 34:55 AI's Impact on Aging Research 39:41 Regulatory Challenges in Longevity Medicine 42:02 Gene Therapy: Opportunities and Risks 46:40 Central Mechanisms of Aging and Reprogramming To learn more about Dr. Matt Kaeberlein:IG: instagram.com/mkaeberlein LinkedIn: https://www.linkedin.com/in/mkaeberlein/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.